OPKO Health
OPK
$1.23
Share price
-1.60%
Change (1 day)
-15.75%
Change (1 year)
Categories
OPKO Health (OPK) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.62 B
According to OPKO Health 's latest financial reports the company's total liabilities are $0.62 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
OPKO Health - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.62 B | 2.79% |
| 2022-12-31 | $0.60 B | -15.25% |
| 2021-12-31 | $0.71 B | -10.84% |
| 2020-12-31 | $0.80 B | 15.41% |
| 2019-12-31 | $0.69 B | 5.26% |
| 2018-12-31 | $0.65 B | -11.6% |
| 2017-12-31 | $0.74 B | 10.6% |
| 2016-12-31 | $0.67 B | -17.65% |
| 2015-12-31 | $0.81 B | 89.71% |
| 2014-12-31 | $0.43 B | -16.7% |
| 2013-12-31 | $0.51 B | 499.12% |
| 2012-12-31 | $86.55 M | 95.72% |
| 2011-12-31 | $44.22 M | -19.3% |
| 2010-12-31 | $54.79 M | -1.86% |
| 2009-12-31 | $55.83 M | 160.83% |
| 2008-12-31 | $21.4 M | -6.05% |
| 2007-12-31 | $22.78 M | 23883.16% |
| 2006-12-31 | $0.09 M | -65.7% |
| 2005-12-31 | $0.27 M | 15.42% |
| 2004-12-31 | $0.24 M | -76.88% |
| 2003-12-31 | $1.03 M | -27.97% |
| 2002-12-31 | $1.44 M | -4.19% |
| 2001-12-31 | $1.5 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 15,769.45% | 🇺🇸 USA |
 Abbott Laboratories ABT | $34.38 B | 5,424.20% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $7.10 B | 1,041.74% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $65.67 B | 10,450.40% | 🇺🇸 USA |
 LabCorp LH | $8.83 B | 1,319.26% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $4.05 B | 550.71% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $35.35 B | 5,579.39% | 🇮🇱 Israel |
 Ardelyx ARDX | $0.13 B | -78.99% | 🇺🇸 USA |